ZA974386B - New formulation for treatment of thromboembolism. - Google Patents

New formulation for treatment of thromboembolism.

Info

Publication number
ZA974386B
ZA974386B ZA9704386A ZA974386A ZA974386B ZA 974386 B ZA974386 B ZA 974386B ZA 9704386 A ZA9704386 A ZA 9704386A ZA 974386 A ZA974386 A ZA 974386A ZA 974386 B ZA974386 B ZA 974386B
Authority
ZA
South Africa
Prior art keywords
thromboembolism
treatment
new formulation
formulation
new
Prior art date
Application number
ZA9704386A
Other languages
English (en)
Inventor
Jan-Erik Loefroth
Lennart Lindfors
Anna-Lena Ungell
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA974386B publication Critical patent/ZA974386B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
ZA9704386A 1996-05-31 1997-05-20 New formulation for treatment of thromboembolism. ZA974386B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602145A SE9602145D0 (sv) 1996-05-31 1996-05-31 New improved formulation for treatment of thromboembolism

Publications (1)

Publication Number Publication Date
ZA974386B true ZA974386B (en) 1997-12-01

Family

ID=20402816

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704386A ZA974386B (en) 1996-05-31 1997-05-20 New formulation for treatment of thromboembolism.

Country Status (14)

Country Link
US (1) US6673365B1 (xx)
EP (1) EP1015022B1 (xx)
JP (1) JP2000511526A (xx)
AR (1) AR013569A1 (xx)
AT (1) ATE284706T1 (xx)
AU (1) AU722450B2 (xx)
CA (1) CA2253410A1 (xx)
DE (1) DE69731981T2 (xx)
ID (1) ID19472A (xx)
NO (1) NO985558L (xx)
NZ (1) NZ332788A (xx)
SE (1) SE9602145D0 (xx)
WO (1) WO1997045138A1 (xx)
ZA (1) ZA974386B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464175A (en) * 1982-08-25 1984-08-07 Altman Alan R Multipurpose tamponade and thrombosclerotherapy tube
AU1629383A (en) * 1982-10-02 1984-04-05 Amano Seiyaku K.K. Earthworm tissue protease thrombolytic agents
EP0662826A1 (en) * 1992-10-02 1995-07-19 Pfizer Inc. Pharmaceutical compositions containing nonionic surfactants
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9302135D0 (sv) * 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation

Also Published As

Publication number Publication date
AU722450B2 (en) 2000-08-03
US6673365B1 (en) 2004-01-06
AR013569A1 (es) 2001-01-10
EP1015022B1 (en) 2004-12-15
SE9602145D0 (sv) 1996-05-31
DE69731981D1 (de) 2005-01-20
ID19472A (id) 1998-07-16
CA2253410A1 (en) 1997-12-04
NO985558D0 (no) 1998-11-27
DE69731981T2 (de) 2005-12-22
JP2000511526A (ja) 2000-09-05
AU3111597A (en) 1998-01-05
ATE284706T1 (de) 2005-01-15
NO985558L (no) 1998-11-27
EP1015022A1 (en) 2000-07-05
WO1997045138A1 (en) 1997-12-04
NZ332788A (en) 2000-05-26

Similar Documents

Publication Publication Date Title
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
ZA971937B (en) Combinations for treatment of proliferative diseases.
ZA986363B (en) Novel method of treatment.
ZA979731B (en) Treatment of asthma.
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
ZA985237B (en) Novel method of treatment.
PL322802A1 (en) Derivatives of 10,13,15-trioxatricyclo[9.2.1.1]-pentadecanone, method of obtaining them and therapeutic agents containing such compounds
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
GB9619492D0 (en) Novel treatment
ZA986364B (en) Novel method of treatment.
ZA976350B (en) Treatment of liquid.
ZA971600B (en) Treatment of macular edema.
ZA986365B (en) Novel method of treatment.
GB9615767D0 (en) Novel treatment
ZA974386B (en) New formulation for treatment of thromboembolism.
ZA977867B (en) Method of treatment.
ZA975637B (en) Method for the treatment of emesis.
GB9608657D0 (en) Novel treatment
GB9726223D0 (en) The treatment of materials
ZA978139B (en) Process for the biological-thermal treatment of waste.
AP2005003432A0 (en) Novel method of treatment.
GB9625795D0 (en) Novel treatment
NZ328739A (en) Treatment of estrogen therapy using 8,9-dehydroesterone
GB9612752D0 (en) Novel treatment
ZA9711116B (en) The treatment of materials.